WE ADD LIFE TO YEARS THROUGH THE POWER
OF RESEARCH
OF RESEARCH
At Biocient, we believe in leaving a mark on history by fundamentally transforming the approach to aging.
Biocient is a next-generation biotechnology company using AI and systems biology to develop therapies for age-related diseases, such as neurodegeneration, metabolic dysfunction, inflammation, and vision decline. Powered by CytoCore platform and a robust multimodal dataset, we are advancing scalable, high-impact solutions that target the root causes of aging.
ABOUT BIOCIENT
Our Foundational Pillars
Our advantage lies in combining cutting-edge science with a platform built for scale. From novel bioactive compounds to patient-specific programs and scalable pipeline, we are positioned to transform treatment across multiple diseases.
A proprietary biotech engine powered by bioactive compounds that act as both fuel and signal for cells.
The CytoCore Platform is Biocient’s proprietary biotech engine built on highly pure, bioactive molecules. These molecules function as both metabolic fuels and cellular signals, providing a powerful foundation for therapies across neurodegenerative, psychiatric, cardiometabolic, and inflammatory diseases.
The CytoCore Platform is Biocient’s proprietary biotech engine built on highly pure, bioactive molecules. These molecules function as both metabolic fuels and cellular signals, providing a powerful foundation for therapies across neurodegenerative, psychiatric, cardiometabolic, and inflammatory diseases.
Biomarker-driven programs tailored to disease stage and patient profile for higher efficacy and lower risk.
Our approach begins with a deep understanding of aging itself—a foundation that drives the discovery of next-generation therapeutic solutions for human health. By addressing the complexity of neurodegenerative conditions, such as Alzheimer’s, we focus on the underlying mechanisms of aging and explore diverse biomarkers with the goal of developing treatments effective across all stages of disease.
Our approach begins with a deep understanding of aging itself—a foundation that drives the discovery of next-generation therapeutic solutions for human health. By addressing the complexity of neurodegenerative conditions, such as Alzheimer’s, we focus on the underlying mechanisms of aging and explore diverse biomarkers with the goal of developing treatments effective across all stages of disease.
A modular, patent-protected system designed to expand into multiple therapeutic areas with reproducible precision.
The CytoCore Platform is modular and expandable biotech engine designed as a repeatable technology system that can evolve into multiple therapeutic directions with strong IP protection and clinical precedent. Our patented manufacturing ensures reproducible purity and biological activity of the molecules.
The CytoCore Platform is modular and expandable biotech engine designed as a repeatable technology system that can evolve into multiple therapeutic directions with strong IP protection and clinical precedent. Our patented manufacturing ensures reproducible purity and biological activity of the molecules.
The CytoCore Platform is Biocient’s proprietary biotech engine built on highly pure, bioactive molecules. These molecules function as both metabolic fuels and cellular signals, providing a powerful foundation for therapies across neurodegenerative, psychiatric, cardiometabolic, and inflammatory diseases.
A proprietary biotech engine powered by bioactive compounds that act as both fuel and signal for cells.
Novel Technology: CytoCore platform
Our approach begins with a deep understanding of aging itself—a foundation that drives the discovery of next-generation therapeutic solutions for human health. By addressing the complexity of neurodegenerative conditions, such as Alzheimer’s, we focus on the underlying mechanisms of aging and explore diverse biomarkers with the goal of developing treatments effective across all stages of disease.
Biomarker-driven programs tailored to disease stage and patient profile for higher efficacy and lower risk.
New Approach
The CytoCore Platform is modular and expandable biotech engine designed as a repeatable technology system that can evolve into multiple therapeutic directions with strong IP protection and clinical precedent. Our patented manufacturing ensures reproducible purity and biological activity of the molecules.
A modular, patent-protected system designed to expand into multiple therapeutic areas with reproducible precision.
Scalable Pipeline and IP Portfolio
Collaborations & Partnerships
We collaborate with leading institutions to accelerate breakthrough discoveries.
